about
Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6Gene from a psoriasis susceptibility locus primes the skin for inflammationAutoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrateMonocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptorsThe G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.Inhibition of RANTES/CCR1-mediated chemotaxis by cosalane and related compounds.Characterization of chenodeoxycholic acid as an endogenous antagonist of the G-coupled formyl peptide receptors.Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain.Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractants.Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood.Painful pathways induced by TLR stimulation of dorsal root ganglion neuronsTriptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and traffickingStructural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticlesThe scaffold protein Cybr is required for cytokine-modulated trafficking of leukocytes in vivo.Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells.An expanding appreciation of the role chemokine receptors play in cancer progression.Negative regulation of CXCR4-mediated chemotaxis by the lipid phosphatase activity of tumor suppressor PTEN.Inducible NOS-induced chloride intracellular channel 4 (CLIC4) nuclear translocation regulates macrophage deactivation.Autoantigens act as tissue-specific chemoattractants.Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells.Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils.Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization.Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cellsAutoantigen signalling through chemokine receptors.Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation.Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor.Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580.Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro.Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells.Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells.Brugia malayi asparaginyl-transfer RNA synthetase induces chemotaxis of human leukocytes and activates G-protein-coupled receptors CXCR1 and CXCR2.Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.Shikonin, a component of antiinflammatory Chinese herbal medicine, selectively blocks chemokine binding to CC chemokine receptor-1.Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function.Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application.Chemokines: progress toward identifying molecular targets for therapeutic agents.Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain.BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice.
P50
Q22010648-C0178546-B5F2-4F61-81B4-ED0CF94C17B7Q24314913-94AFB65F-60F0-4607-B2A0-56D9225D6D7FQ24670380-7B95A14C-A357-44A6-979B-37A2DB49AF9FQ28235818-7957CFF5-32BD-438C-9A32-B20FBE5D8107Q30493852-8DFBA607-AB33-4C82-BE9E-638EEDB0F772Q31805182-F4861FC2-2749-4392-A935-355A28E2CE46Q32043427-0FD7137E-7A79-4461-ADF2-42A121D78E92Q34074221-671F1DF4-7295-4ED7-BA23-A0F293DE3C25Q34114893-F59DDBF0-8502-43E1-ACA6-2B564A2F69C2Q34224950-7B03A232-FBE6-4631-99BC-0175DEA074CCQ34362854-6E473308-E5F9-400E-9E49-0329F6AB09F8Q34985717-12FD815A-3864-43F6-BF76-BBD77CC8F7C7Q34995441-60382F1F-B42D-4975-A8FC-9B23C5987B87Q35039049-7DF9AAF8-ECE0-4243-821D-B6B07AE7BD33Q35049224-243EBC4D-9C29-4430-9C34-8DF775F03892Q35070890-1D3E4CE0-C353-47E2-9A5B-61AE204EB6B3Q35157701-8F65CB10-0E5B-4601-B7B1-3ED0F09AAD23Q35848295-0029E28E-D8D8-4BF7-8030-B33363B76A13Q35848387-85E72365-BE44-4694-9AD3-FFF69A60FE72Q35924830-5A81CDCD-DA8C-4A53-A5A1-FB53A0DC485AQ36139951-F37B445F-8562-4C33-9907-8E98A627DA2FQ36368272-CC72BB45-CE91-4A46-9267-E17008BF1554Q36380472-CC5CC96C-7937-4AED-9E13-29477B3D9770Q36401415-730915E5-9C66-4A93-A06E-B60144DE287DQ36420714-2DDF8C0F-71C6-465A-8CA3-5EC422CDF607Q36629610-C9413C97-D6C3-4323-9B0C-3195513FB909Q37090449-D715F3E9-C564-4EEC-A6A1-64950DF0B3E1Q38346347-1489FDB2-D466-480A-9014-FADF2D0CCE54Q38360159-602BA037-9271-46B6-AE1B-9B6F7BF60420Q39296482-64E18F29-0681-4CBA-9145-211A9BB5182CQ39696464-25A6C8F2-61B2-4567-A557-C20C2DA1853CQ40118463-412F7EBD-950D-4A29-B41E-EF22793106CDQ40303264-CAE321D8-7830-40CA-B3E3-2B2CB75A7AFFQ40414882-B3FC287C-EE0F-449D-95B5-055584D5B250Q40707327-7A7F5F62-123A-4AD0-81D1-8BDCC7565DD8Q40951718-63E12F46-9E74-418B-8408-0DD756573A38Q41033142-9B0DE2D2-0286-426F-99D1-4FB38753D3B6Q41068981-68042F10-DC31-4D98-9B27-BA70FD5EEA4DQ41286723-26DF1D76-2CD2-4E6C-AAB0-A7EB94DD05DFQ42654151-A93E1630-6E07-41DE-8407-2FC56CFC5A76
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
O M Howard
@es
O M Howard
@nl
O M Howard
@sl
O M. Howard
@en
O. M. Howard
@fr
type
label
O M Howard
@es
O M Howard
@nl
O M Howard
@sl
O M. Howard
@en
O. M. Howard
@fr
altLabel
Zack Howard
@en
prefLabel
O M Howard
@es
O M Howard
@nl
O M Howard
@sl
O M. Howard
@en
O. M. Howard
@fr
P1053
B-6117-2012
P106
P1153
7005252471
P31
P3829
P496
0000-0002-0505-7052